Generative artificial intelligence creating new errors and omissions risks: Lloyd’s

Lloyd’s Market Association warned that growing reliance on generative artificial intelligence by professional services firms is introducing new exposures for the international errors and omissions market, citing liability for mistakes, data breaches and regulatory challenges.

The Lloyd’s Market Association warned that growing reliance on generative artificial intelligence by professional services businesses is creating new risks for the international errors and omissions market, Business Insurance reported. The association’s concern was cited in coverage from Continuity Insurance & Risk Magazine, and Business Insurance linked to the original story. The report frames the trend as a market-level issue driven by increased deployment of generative artificial intelligence tools across professional services.

According to the coverage, some of the specific risks generative artificial intelligence poses for businesses include liability for mistakes, data breaches and regulatory challenges. Those items were highlighted as emerging exposures that could affect error and omission claims and underwriting for firms that incorporate generative artificial intelligence into client work or internal processes. The article presents these categories as the primary near-term concerns identified by the Lloyd’s Market Association and reported by Continuity Insurance & Risk Magazine.

The short notice does not provide further detail on several points. It does not identify which professional services sectors are most affected, it does not quantify potential losses or changes to underwriting, and it does not describe specific mitigation measures or insurer responses. Business Insurance included a link to the original Continuity Insurance & Risk Magazine story for readers seeking more detail: https://www.cirmagazine.com/cir/c2025091803.php. The Business Insurance item was published on Sep 19, 2025, and focuses on the association’s warning rather than detailed case studies or policy changes.

50

Impact Score

HMS researchers design Artificial Intelligence tool to quicken drug discovery

Harvard Medical School researchers unveiled PDGrapher, an Artificial Intelligence tool that identifies gene target combinations to reverse disease states up to 25 times faster than current methods. The Nature-published study outlines a shift from single-target screening to multi-gene intervention design.

How hackers poison Artificial Intelligence business tools and defences

Researchers report attackers are now planting hidden prompts in emails to hijack enterprise Artificial Intelligence tools and even tamper with Artificial Intelligence-powered security features. With most organisations adopting Artificial Intelligence, email must be treated as an execution environment with stricter controls.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.